Actualités sur Medikament
- plus
ZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospital
plusSchweizerischer Nationalfonds / Fonds national suisse
Clinical research: patients and the public have their say
Bern (ots) - The Swiss National Science Foundation has been funding clinical studies on under-researched topics in medicine since 2016. In a first, it successfully involved representatives of patients and the public in evaluating applications. The aim of the SNSF's Investigator Initiated Clinical Trials (IICT) programme is to answer medical questions that are important to society but not a priority for industry. This ...
plusServier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
Paris (ots/PRNewswire) - Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases. Under the collaboration ...
plusCOVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them
Nyon, Switzerland (ots/PRNewswire) - New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. Today sees the launch of Let's treat it right, a major new health education campaign designed to bridge a knowledge gap ...
plusAlmirall and MC2 Therapeutics announce completion of decentralized procedure in Europe for the topical treatment of mild to moderate psoriasis vulgaris in adults
Barcelona, Spain and Copenhagen, Denmark (ots/PRNewswire) - - The successful completion of a decentralized procedure is the final step before national marketing authorizations can be granted by the European countries - MC2 Therapeutics has granted Almirall exclusive European rights to commercialize this topical ...
plusTianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
Wuhan (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This short ...
plusTianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM
Tianjin, China (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This ...
plus- 3
Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access
plus European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
Brussels and Castres, France (ots/PRNewswire) - Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients ...
plusPionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients
South San Francisco, Calif. and Cambridge, England (ots/PRNewswire) - - The partnership will support the progression of PY314, the first of Pionyr's Myeloid Tuning(TM) antibodies to enter the clinic - Pionyr will use Abcam's EPR20243 clone to evaluate TREM2 levels in tissue samples for potential future development ...
plusValcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations
Copenhagen (ots/PRNewswire) - Valcon Medical A/S ("Valcon Medical" or the "Company"), Denmark's leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021. Under the DKMA ...
plusEpredia And Aiforia Announce Partnership For Global Distribution Of AI-powered Pathology Software
Portsmouth, N.h. (ots/PRNewswire) - Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for ...
plusNorgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.
Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. (Beijing Podconley), today announced an exclusive distribution agreement by which Beijing Podconley will commercialise Norgine's product ...
plusTNO research shows effectiveness of corona cannon
Rijswijk, Netherlands (ots/PRNewswire) - Addition due to incomplete information in the press release as sent on 4 June 2021 Analyses carried out by TNO in a BSL-3 laboratory cabinet showed that the corona gun had achieved a 94.9% reduction in the Covid -19 virus after 15 minutes. In the laboratory set-up, the (live) virus was located on stainless steel plates at 85 cm from the device. Earlier, the Dutch scientific ...
plusBIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June
Porto, Portugal (ots/PRNewswire) - The second edition of the BIAL Award in Biomedicine is currently underway. Worth three hundred thousand Euros, this prize is intended to reward a work with exceptional quality results and scientific relevance published in the last ten years in the broad field of biomedicine. The winner will be chosen by an independent and ...
plusBiobeat Launches Wearable Continuous Ambulatory Blood Pressure Monitoring (ABPM) Device
Petah Tikva, Israel (ots/PRNewswire) - New Clinical Data Supports Use of Biobeat ABPM Cuffless-Monitor as Reliable and Accurate Solution for Out-of-Clinic Blood Pressure Monitoring Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable and continuous ambulatory blood pressure ...
plusRoche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
plusSemaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to ...
plusRoche collaborates with Lilly to support people with diabetes on insulin pen therapy
Basel, Switzerland (ots/PRNewswire) - - Roche and Lilly will integrate data from Lilly's connected insulin pen solution into the mySugr app in several countries. - Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. - By ...
plusRoche collaborates with Lilly to support people with diabetes on insulin pen therapy
Basel (ots) - ● Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. ● Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. ● By collaborating with Lilly, ...
plusPain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs
Ramat Gan, Israel (ots/PRNewswire) - A new study from Leiden University in the Netherlands has found that monitoring pain response levels during surgery with NOL® technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Extrapolating the results of this study, an economic analysis has shown that by facilitating reduced postoperative pain, using ...
plusSchweizerischer Nationalfonds / Fonds national suisse
937 million Swiss francs for 3300 new research projects
Bern (ots) - In 2020, researchers submitted 8200 grant applications to the SNSF. 3300 of them were selected for funding in a competitive process. At short notice, the SNSF funded 73 projects on COVID-19. Thousands of SNSF-funded teams explore nature, technology and society. This generates knowledge that is a key driver of progress. In 2020, the SNSF invested 937 million francs in 3300 new projects, selected from 8200 ...
plus#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month
Lausanne, Switzerland (ots/PRNewswire) - - Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition - #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular ...
plusZentiva Continues Its Expansion In Oncology With The Launch Of ALYMSYS® (bevacizumab) In 21 Countries Across Europe
Prague (ots/PRNewswire) - Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS® (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on a comprehensive clinical and scientific package which demonstrated biosimilarity of ALYMSYS® to the ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Veal calf fattening: it can work with less antibiotics
Bern (ots) - By adopting a few simple measures, farmers can drastically reduce the use of antibiotics and improve the well-being of their animals without economic disadvantages. This was confirmed in a field trial- the first of its kind in Switzerland - carried out by researchers of the University of Bern based on the specially developed "outdoor veal calf" method. Large amounts of antibiotics are used in the veal ...
plusGrünenthal is Recognized for its Strong Management of Environmental, Social and Governance (ESG) Risks
Aachen, Germany (ots) - - Leading global ESG ratings agency Sustainalytics notes Grünenthal is in the top five percent among its peers in the pharmaceutical subindustry - Grünenthal is categorized as “medium risk”, placing it ahead of its key subindustry peers and in the same league as multinational companies ...
plusSaxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12-17 years
Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda® is expanded for the treatment of obesity in adolescents aged 12-17 years.1 Over the last 20 years, the ...
plusPromising results from Liechtenstein study on early detection of Covid-19 / Sensory bracelet indicates infection two days before appearance of first symptoms
Vaduz (ots) - A scientific consortium led by Liechtenstein scientists and entrepreneurs Lorenz Risch and Martin Risch launched the prospective "COVI-GAPP study", involving more than 1100 subjects from the Principality of Liechtenstein, in April 2020. The aim was to show whether a sensory bracelet, already used ...
plusDental disaster: One year after first lockdowns dentists around the world confront the consequences of the COVID-19 pandemic on people’s oral health: higher incidence of tooth decay and more advanced gum disease
plus